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Background: The deficiency of human acid beta-glucosidase (hGCase) causes Gaucher disease, a rare
genetically-inherited disorder currently treated by enzyme replacement therapy using recombinant CHO-derived
GCase. In an attempt to provide an alternative and more efficient production system, a chimeric cDNA coding for
hGCase operatively linked to the signal peptide of rice glutelin 4 (GluB4) was put under the control of the GluB4
endosperm-specific promoter and inserted into the genome of a waxy rice.
Results: Molecular, immunological and biochemical analyses showed that recombinant hGCase, targeted to the
protein storage vacuoles of rice endosperm cells, is equivalent to the native protein and has a glycosylation pattern
compatible with direct therapeutic use. Compared to a previous study carried out on transgenic tobacco seeds,
enzyme contents per unit of biomass were drastically increased; in addition, differently from what observed in
tobacco, rice seed viability was unaffected by hGCase even at the highest production level. Transgenic seed
polishing combined with a pretreatment of seed flour greatly facilitated hGCase extraction and purification with an
industrially-scalable procedure.
Conclusions: This study opens up the possibility to efficiently produce in the rice seed pharmaceutical compounds
which are available in limited amounts or completely excluded from clinical practice due to the inadequacy of their
production systems.
Keywords: Human acid beta-glucosidase, Gaucher disease, Transgenic rice, Pharmaceutical proteins,
Endosperm-specific expression, Molecular farmingBackground
Human acid beta-glucosidase (hGCase; EC 3.2.1.45) cat-
alyzes the hydrolytic cleavage of glucose from glucosyl-
ceramide in lysosomes (Brady et al. 1965). It is a
homomeric glycoprotein of 497 amino acids with a mo-
lecular mass ranging from 60 to 68 kDa, containing five
putative N-glycosylation sites, four of which are nor-
mally occupied (Berg-Fussman et al. 1993; Brumshtein
et al. 2006). The quantitative/qualitative deficiency of
hGCase leads to an accumulation of glucosylceramides
in lysosomes and causes the Gaucher disease (GD), one
of the most frequent human sphingolipidosis. Fatty ma-
terial can collect in the spleen, liver, kidneys, lungs, brain* Correspondence: stefano.marchetti@uniud.it
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in any medium, provided the original work is pand bone marrow. Main clinical symptoms may include
hepatosplenomegaly, anaemia, thrombocytopenia and
skeletal deterioration (Beutler and Grabowsky 2001). GD
has a pan-ethnic diffusion but its frequency is particu-
larly high (1:640 to 1:10,000) in the Ashkenazi Jewish
population (Beutler and Grabowsky 2001; Cox and
Schofield 1997), whereas in the non-Jewish population
data are varying from 1:57,000 to 1:200,000 (Cox and
Schofield 1997; Meikle et al. 1999).
GD is currently treated by enzyme replacement therapy
(ERT) using mainly a recombinant processed form of
human acid beta-glucosidase (commercial imiglucerase)
obtained from cultured CHO cells. Regular infusions of
the missing enzyme were found effective in reducing the
visceral and bone marrow storage of glucosylceramides,
decreasing spleen and liver volumes, normalizing/stabiliz-
ing hematochemical parameters (Hb, platelets, hepatic
enzymes, chitotriosidase) and improving the quality of lifeOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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1998). However, the current production system based on
CHO is economically very expensive and limits the drug
amounts present on the market, seriously hindering the
maintenance and the diffusion of therapeutic regimes.
Moreover, an acute shortage of commercial imiglucer-
ase has recently occurred as a result of viral contamin-
ation of the production facility, forcing all countries to
reassess their stocks and to establish new priorities of
drug supply to patients (Hollak et al. 2009).
Although an additional two enzymatic forms were
approved for early access clinical programs, i.e. velaglucer-
ase alpha (from cultured human fibroblasts; Aerts et al.
2010) and taliglucerase alpha (from cultured carrot cells;
Shaaltiel et al. 2007, Aviezer et al. 2009), the drug shortage
has underlined the necessity to find a valid alternative pro-
duction system to guarantee sufficient drug supply to
patients not only for Gaucher disease, but also for other
disorders and diseases curable with lifelong therapies.
Molecular farming, i.e. the production of valuable re-
combinant proteins in plants (Schillberg et al. 2003), can
represent a good solution to this need, because plants
have several advantages over traditional platforms for re-
combinant pharmaceutical protein production. Plants
are inexpensive, they are highly scalable, they offer high
product quality and they do not support human patho-
gens. Crops producing pharmaceutical molecules can be
established with minimal upfront investment in infra-
structures, unlike the major fermentation-based plat-
forms (Fischer et al. 2012).
Concerning Gaucher disease, in a previous study, a pro-
cedure for production and immuno-purification of human
acid beta-glucosidase in tobacco seeds was developed
(Reggi et al. 2005). The plant-derived enzyme was found
stable, active and taken up by human target cells; never-
theless, it was also found that the best transgenic lines
could not be maintained through sexual reproduction due
to seed non viability; this fact combined with the tiny
dimensions and the high lipid content of tobacco seed had
a negative impact on industrial scalability.
The present paper describes a novel technological plat-
form for the large-scale production of recombinant
human GCase (rhGCase) in the endosperm of Oryza
sativa L. In the new system, seed germination is not
impaired by the recombinant enzyme, protein extraction
and purification can be easily performed with resins
available in bulk amounts and the product quality
appears largely suitable for therapeutic purposes.
Results
Rice transformation and molecular analyses on
primary transformants
Compared to other japonica varieties, the waxy rice CR
W3 is less responsive in vitro, therefore preliminaryexperiments were done to select the best conditions for
embryogenic callus formation and plant regeneration.
Agrobacterium-mediated transformation was efficient
only when scutellum-derived calli were less than 1 mm
in diameter, non-friable, whitish and roundly shaped;
moreover, such calli had to be used within 10 days after
isolation and selection. Regenerated plants were analysed
by PCR to verify the presence of both hGCase and selec-
tion marker genes (Figure 1). A total of 67 plants were
found positive and used for further analyses. A sample
of 16 randomly-chosen transformants was used to esti-
mate the transgene copy number by real-time qPCR. In
these experiments, the endogenous reference was the su-
crose phosphate synthase (SPS) gene, which is present in
a single copy in the haploid rice genome. Titration
curves were obtained by regressing threshold cycles on
known dilutions of SPS and hGCase genes; correlation
coefficients between the two variables ranged from 0.985
to 0.993. PCR efficiencies were above 0.90. In the sample
of primary transformants, transgene copy number was
in most cases ≤ 3 and never higher than 4.
Western blot analyses on seed protein extracts
As formerly described, the human GCase gene was
linked to an endosperm-specific rice glutelin (GluB4)
promoter, enhanced by the substitution of its native
leader region with the synthetic LLTCK 5’ UTR (De
Amicis et al. 2007). To confirm the endosperm expres-
sion of the GluB4 promoter, seed protein extracts were
analyzed by Western blotting using the anti-GCase
serum raised in rabbit after injection of the GCase-
analogue imiglucerase. These analyses demonstrated that
rhGCase is accumulated in the developing seed. No
cross-reacting proteins were ever identified in seed pro-
tein extracts of untransformed control. In all transgenic
samples, the antibody revealed a single protein band,
having an apparent molecular weight of 60 kDa, that is
very similar to commercial imiglucerase (Figure 2). Since
the molecular mass of the unglycosylated protein is
55.6 kDa, this result indicated that rhGCase produced in
the rice endosperm is glycosylated with low molecular
weight N-glycans.
The Western blot signal intensity differed among lines;
since in a previous study the band intensity was found
correlated with rhGCase content (Reggi et al. 2005),
Western blotting was used to select the best primary
transformants, until a consistent ELISA was developed.
The protein extracts of 18 transformants repeatedly gave
better results; this superiority was confirmed in Western
blot analyses carried out using different sample dilutions.
Best transformants were grown to produce a T2 gener-
ation for further quantitative analyses, whereas the seed
of the remaining lines was bulked and used to develop
the GCase purification procedure.
Figure 1 Duplex-PCR products obtained using primers specific for hGCase and hpt-II (hygromycin resistance) genes. Lane 1: 1 kb ladder
(NEB); 2: negative control (untransformed CR W3); 3–18: tested plants.
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The glutelin 4 signal peptide was used with the expect-
ation that rhGCase would be targeted to the protein
storage vacuoles (PSVs) within the endosperm cells. To
precisely determine the site of rhGCase accumulation
and storage, transformed and untransformed seeds were
repeatedly examined at the transmission electron micro-
scope following immunogold labeling. Since this im-
munocytochemical technique does not preserve the
ultrastructural morphology of the tissues, the main cel-
lular ultrastructures of rice seed endosperm were pre-
liminary identified in osmium-treated samples
(Figure 3A). No signal was ever found in untransformed
control seed; differently, in transgenic seed the presence
of the recombinant enzyme was revealed exactly where
it was planned, i.e. within protein storage vacuoles
(PSVs) of the seed endosperm (Figure 3C); interestingly,
no immunogold labeling was obtained in the protein
bodies.Tissue-specific expression analyses
Protein samples extracted from different tissues/organs
showed the typical electrophoretic pattern; no difference
was noted between the transgenic line and the CR W3 var-
iety providing the genetic background (Figure 4B and 4D).
Western blot analyses indicated the endosperm-
specific expression of rhGCase (Figure 4A). No cross-Figure 2 Western blot analysis of crude seed protein extracts.
Lane 1: Precision Plus Protein standard (BioRad); 2: positive control
(100 ng imiglucerase); 3: negative control (protein extract from
untransformed CR W3 seed); 4–10: tested plants.reacting protein appeared in the negative control CR
W3 (Figure 4C).
Results obtained with DAS-ELISA were consistent in
showing the endosperm-specific expression of the
rhGCase gene (Figure 5). Some background noise was
evidenced for root and embryo protein extracts but the
overall clearness of the data was not hampered in any
respect.
rhGCase extraction and purification
On the basis of the endosperm-specific localization of
rhGCase, a first trial took into consideration the possible
advantage of seed polishing for the partial removal of
protein contaminants. Transgenic white rice was milled
and analysed in parallel with the polishing waste. From
the combination of the results obtained in SDS-PAGE
and Western blotting, it appeared that, differently from
the large part of contaminants, only a minimal quantity
of rhGCase is removed during processing (Figure 6).
Subsequent experiments were designed to determine the
conditions for rhGCase extraction from polished seed
flour. Figure 6 shows the results obtained in 5 and 2 ser-
ial extractions carried out on the polished seed flour and
the polishing waste, respectively. It is evident from the
figure that most rhGCase is recovered from flour with
the first three extractions and that in the fifth extract the
enzyme is hardly detectable. Percent enzyme recovery as
estimated by ELISA in the first, second and third extrac-
tion was 64.7, 22.9 and 7.2%, respectively.
DAS-ELISA was also used to determine the rhGCase
content in polished rice flour derived from a bulk of
unselected seeds harvested from the best primary trans-
formants. The overall estimated yield was 143 mg of
rhGCase per kg of flour.
With respect to rhGCase purification, the high ionic
strength of the extract superimposed the choice of HIC
(Hydrophobic Interaction Chromatography) for GCase
capturing and IEC (Ion Exchange Chromatography) for
intermediate purification. All chromatographic fractions
were analysed by ELISA, SDS-PAGE and Western blot-
ting. Under the conditions reported in this paper, both
chromatographies were quite efficient in enzyme recov-
ery as well as in the exclusion/removal of contaminants.









Figure 3 Electron and immunoelectron microscopy on rice
endosperm sections. Micrograph of unlabelled osmium-treated
sample (A), untransformed control (B) and transformed rhGCase
seed (C). PSV: protein storage vacuole; PB: protein body; S: starch
granule. Bars = 3 μm in (A), 1 μm in (B) and (C).
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after a retention volume equal to 56.4 mL, which was
very close to that of commercial imiglucerase, equal to
55.9 mL. Total removal of contaminants was confirmed
in SDS-PAGE (Figure 7) and ELISA analyses based on ti-
tration curves made with commercial therapeutic-grade
imiglucerase. Data regarding the efficiency of each chro-
matographic step are shown in Table 1.
Seed viability
Percent viability was excellent (99-100%) in both trans-
formed seed samples and untransformed control. No
dormancy was recorded in any seed lot, consistently
with previous observations on germination behaviour of
the CR W3 variety. As shown in Figure 8A, seed viability
and the time course of germination were similar for un-
transformed control and two transformants with a
sharply different rhGCase content (63.5 and 215 mg per
kg of flour). In contrast, best tobacco transformants pro-
duced according to Reggi et al. (2005) had a seed ger-
mination capacity equal to zero (Figure 8B). It is worthy
of note that the best tobacco plant had 32 mg rhGCase
per kg of seed flour, i.e. approximately one half of the
enzyme content recorded in the rice lower producer.
This evidence demonstrates that rhGCase accumulation
and seed germination can be effectively uncoupled
through endosperm-specific expression in a monocot
system.
Peptide mass fingerprinting and N-terminal sequencing
MALDI-TOF analysis carried out on a purified rhGCase
sample digested with trypsin confirmed its equivalence
with human GCase [GenBank: J03059]. The results
achieved with the Mascot proteomic software (www.
expasy.org/tools) were clear-cut: rhGCase identification
was obtained with a score of 10-32 and the percent
protein coverage was equal to 53% (Figure 9). It is
interesting to note that both the amino- and the carboxy-
terminus of the protein were included in the list of recog-
nized peptides and that they resulted fully equivalent
with the corresponding sequences of human GCase.
Differently, the peptides containing the first, second and
fourth N-glycosylation site were not detected through
the Mascot analysis, because in all likelihood these sites
were occupied by oligosaccharidic chains. More details
on glycan structure are reported hereinafter.
The identity of the rhGCase N-terminal sequence was
also determined through conventional Edman analysis.
The resulting data confirmed that the first 9 amino acids
of rhGCase correspond exactly to the first tract of the
human mature polypeptide. Hence, it was demonstrated
again that the signal peptide of glutelin 4 is well recog-
nized and properly removed from the precursor protein
during traslocation in the ER.
Figure 4 Detection of rhGCase in protein extracts from different tissues of transgenic and wild type plants. A and C: Western
blot analyses performed using an anti-rhGCase polyclonal antibody; B and D: SDS-PAGE and Coomassie staining of the same protein samples of
A and C, respectively.
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N-glycosylation was partially characterized by digesting
a purified rhGCase sample with PNGase F. MALDI-
TOF data processing of the oligosaccharidic chains sug-
gested the presence of 12 glycan forms. Figure 10
reports the glycan structures identified in rhGCase with
the Glycomode software tool (www.expasy.org/tools). AllFigure 5 Results of DAS-ELISA analyses carried out on protein sample
plants. O.D.: optical density.oligosaccharide chains shared the typical paucimannosidic
structure of N-linked glycans of PSV proteins (Lerouge
et al. 1998). In all cases but one, they were found to have
at least one chain-terminating mannose residue needed
for GCase uptake by human cells. Even though MALDI-
TOF analysis does not allow a precise quantification of the
different forms, mass spectra showed that Man3GlcNAc2s obtained from different tissues of transgenic and wild type
Figure 6 SDS-PAGE and Western blot analyses of crude protein samples obtained during extraction trials. Lanes 1–5: serial extractions
from polished seed; lanes 6–7: serial extractions from polishing waste. PC (positive control): 100 ng imiglucerase.
Figure 7 SDS-PAGE analysis carried out to estimate
contaminant removal obtained in each chromatographic step.
Lane 1: HIC (Hydrophobic Interaction Chromatography) eluate; 2: IEC
(Ion Exchange Chromatography) eluate; 3: GF (Gel Filtration) eluate.
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most abundant. Differently, glycoforms with a mass
greater than 1.3 kDa were detected at much lower levels.Enzyme activity
Similarly to what was found in tobacco leaf and seed
extracts (Reggi et al. 2005), a straightforward determin-
ation of rhGCase content in polished seed by enzymatic
assay was prevented by the presence of an intrinsic
GCase-like activity. No investigation was made on the
enzyme(s) responsible for that, essentially because this
endogenous component was completely separated from
rhGCase during IEC (Figure 11). Hence, enzymatic
assays were conducted only on purified rhGCase, using
commercial imiglucerase as positive control. In particu-
lar, 5 ng of the commercial standard showed an average
specific activity of 9.2 μmol/min/mg; equal amounts of
rhGCase from three independent lots were repeatedly
found in the range of 7.9-9.7 μmol/min/mg.Table 1 Efficiency of chromatographic steps in rhGCase
purification
Chromatographic step HIC IEC GF
GCase recover 73.3% 75.9% 74.3%
Cumulative GCase loss 26.7% 44.4% 58.7%
Removal of contaminants 98.4% 82.9% 100%
Cumulative removal 98.4% 99.7% 100%
Figure 8 Results of seed viability tests in rice and tobacco. A: untransformed and transformed rice seeds; B: untransformed and transformed
tobacco seeds.
Figure 9 MALDI-TOF analysis of a rhGCase sample purified by HIC and IEC chromatography. Red bars indicate rhGCase tryptic peptides
assigned to human GCase regions. The position of the five putative N-glycosylation sites is shown by circles; all sites except the last one, which
never harbours glycans (Berg-Fussman et al. 1993), are normally occupied by oligosaccharidic chains.
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Figure 10 N-glycan structures and related molecular masses predicted in rice-derived rhGCase by Glycomode analysis.
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Among different methods described for the production
of recombinant proteins in plants, those involving the
seed are particularly attractive because seeds are natural
organs devoted to the production and accumulation of
storage proteins in a small volume and in a stable bio-
chemical environment. In particular, neo-synthesized
proteins are targeted to subcellular storage compart-
ments such as protein bodies and protein storage
vacuoles, where they can be preserved for a long time
due to a low water content and the presence of protein-
ase inhibitors (Takaiwa et al. 2007).Figure 11 Fluorescence recorded in comparative 4-MUG catalytic assa
untransformed CR W3; TR: transformed CR W3 plants; E1-E8: elution fractionIn former experiments (Reggi et al. 2005), it was
demonstrated that recombinant human GCase can be
stored in a stable and active form in tobacco seed. How-
ever, in the best primary transformants, seed viability
appeared totally impaired and all attempts to overcome
the problem were unsuccessful (Reggi et al. 2005). This
evidence, together with a high oil content and tiny di-
mension of tobacco seed, prompted us to consider rice
as an alternative host-species.
In seed-specific expression studies carried out in
tobacco, recombinant proteins are typically accumulated
in the cotyledon parenchymatic tissue, hence they canys performed on 8 IEC elution fractions. NC (negative control):
s; PC (positive control): 100 ng imiglucerase.
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mination. Differently, in rice there is the opportunity to al-
locate recombinant proteins in the endosperm, i.e. a tissue
separated by the embryo and metabolically inert at matur-
ity. Beside this, rice seeds can be industrially processed to
separate the hulls, the germ and the aleuronic layer. The
removal of these components, which is relatively inexpen-
sive, greatly favours the extraction and purification of
heterologous proteins because both the lipid content and
the number of protein contaminants are minimized.
Among other advantages in using rice as bioreactor,
there is the availability of some non-food varieties with
easily-recognizable genetic markers (Takaiwa et al. 2007).
In this work, essentially for biosafety issues, the japonica
waxy rice CR W3 was used; CR W3 is a registered variety
with round-shaped seed developed by the Rice Research
Centre of Ente Nazionale Risi (Milan, Italy) but insofar
awaiting commercial exploitation. Due to an almost void
amylose content, CR W3 seed can be used for the produc-
tion of starch and related byproducts, whereas its employ-
ment as human food is difficult for the remarkable loss of
consistency with boiling.
The endosperm-specific accumulation of rhGCase in
CR W3 seed was gained through the use of the rice glu-
telin 4 promoter (GluB4pro). In a former study carried
out with different seed-specific promoters (Qu and
Takaiwa 2004), GluB4pro determined the highest level of
GUS expression in transgenic rice. The maximum accu-
mulation of the GUS protein was observed in the inner
starchy endosperm, close to the late maturation stage.
In our experiments, GluB4pro showed a similar expres-
sion pattern: in fact, rhGCase was detected exclusively in
the seed endosperm and not in other vegetative or repro-
ductive tissues; moreover, SDS-PAGE and Western blot-
ting analyses indicated that only negligible amounts of
rhGCase are lost with seed polishing, a process that elimi-
nates the germ and the aleuronic/sub-aleuronic layers
(Figure 6).
Much interestingly, neither seed viability nor dor-
mancy were affected by rhGCase endosperm-specific ex-
pression; in all instances percent viability was excellent
(99-100%) and resembled that of untransformed control.
These data clearly demonstrate that the problem of seed
viability loss recorded for tobacco plants (Reggi et al.
2005) is non-existent in rice.
It is important to underline that, despite seed protein
content is significantly lower in rice compared to
tobacco, in rice endosperm rhGCase expression levels
were found much greater than those recorded in the
best tobacco transformants, perhaps due to more per-
missive physiological conditions and the triploid nature
of the tissue. The achievement of high transgene expres-
sion levels is crucial for developing a technological plat-
form for industrial scale-up; beside promoters, severalmolecular elements must be considered, including 5’
UTR and the signal peptide sequence for specific subcel-
lular localization. For the purpose of this study, the
GluB4 native leader was replaced with the artificial
leader LLTCK (De Amicis et al. 2007) mainly character-
ized by the combination of a poly(CAA) region with a
CT-rich motif. In previous studies, the LLTCK leader
determined a 12.5-fold enhancement of uidA expression
in tobacco leaf as compared with the native CaMV 35S
leader sequence (De Amicis et al. 2007). No experimen-
tal evidence about the utility of LLTCK in monocot
plants has been published so far; it should be noted
however that, although not in association between each
other, CT- and GA-rich regions occur in the proximity
of the transcription start site of many plant genes, par-
ticularly in monocots (Chen et al. 1996).
As far as subcellular targeting is concerned, its influence
on folding, assembling, post-translational modifications
and stability of a protein is widely recognized (Twyman
et al. 2003; Doran 2006; Benchabane et al. 2008). In this
study, the signal peptide of glutelin 4 (SPGluB4) was used;
immunolabelling results demonstrated that this SP deter-
mined a rhGCase accumulation in the same storage com-
partment of GluB4, i.e. the protein storage vacuoles
(PSVs) (Takaiwa et al. 1999; Kawakatsu et al. 2008).
Similarly to other PSV-allocated recombinant proteins
(Humphrey et al. 2002; Arcalis et al. 2004; Vitale and
Pedrazzini 2005), both rhGCase content and activity
were maintained unaltered after 12 months of storage
(data not shown).
The use of a signal peptide for ER-targeting is an
acquainted technology; a more challenging aspect is
represented by the prediction of both SP removal and
cleavage site. If the SP is not separated from the protein,
the precursor-complex can remain anchored to the ER
outer membrane (Yan et al. 1997) and in any case it does
not assume the correct tertiary structure. On the other
hand, if the SP is removed but cleavage does not occur in
the exact position, different non-authentic versions of the
mature protein may arise. This condition is absolutely det-
rimental for therapeutic proteins since mutated forms are
potentially immunogenic or provided with different phar-
macodynamic properties. Some software tools were
devised for prediction of the SP cleavage site in different
host systems (Emanuelsson et al. 2007). In the present
work, both SignalP 3.0 (http://www.cbs.dtu.dk/services/
SignalP) and SIG-PRED (http://bmbpcu36.leeds.ac.uk/
prot_analysis/Signal.html) were preliminary used to deter-
mine the probability of proteolytic cleavage of SPGluB4/
GCase complex; in either case, the predicted site corre-
sponded exactly to the boundary between SPGluB4 and
mature GCase (MATIAFSRLSIYFCVLLLCHGSMA//
ARPCIPKSF. . .). In fact, N-terminal sequencing revealed
that SPGluB4 is well recognized and correctly removed,
Figure 12 Scheme of the pTRS0_GCase vector. The rhGCase
cassette and the restriction sites used for sequence assembly are
highlighted. Abbreviations: Glub4pro/LLTCK = rice glutelin 4
promoter with LLTCK 5’ UTR; SPGluB4/GCase = hGCase gene with
the signal peptide of rice glutelin 4; NOS-ter = nopaline synthase
terminator.
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quence is perfectly identical to the human one.
Another important issue for injectable proteins pro-
duced in plants concerns the type and level of N-glycosy-
lation. Glycan analyses performed by MALDI-TOF on
oligosaccharide chains of rice-derived GCase revealed that
11 out of 12 predicted glycoforms are mannose-ending,
which is an essential pre-requisite for human cell internal-
ization. This represents a further advantage in the clinical
use of rice-derived GCase in comparison with CHO-
derived molecule. In fact, the latter must be partially
deglycosylated in order to expose mannose residues which
are specifically recognized by endocytic carbohydrate
receptors on macrophages of reticulo-endothelial system.
This enzymatic process complicates the purification step
and increases production costs (Futerman et al. 2004).
Preliminary assays conducted on human target cells
demonstrated that the rice seed-derived enzyme is well-
recognized and taken up at levels comparable to those of
the commercial imiglucerase (data not shown).
Conclusions
This paper describes an industrially-scalable method to
produce human acid beta-glucosidase in rice endosperm.
Likewise, the same procedure can be applied to efficiently
produce pharmaceutical compounds which, similarly to
rhGCase, are potentially harmful to the plant cell.
The platform overcomes some important difficulties
faced in previous work, more specifically:
– it allows a tissue-specific expression and a consistent
subcellular localization of human acid beta-glucosidase
inside the rice seed;
– it allows the production of a pharmaceutical molecule
suitable for therapeutic use;
– it does not affect seed viability thus enabling the
maintenance and multiplication of productive lines
through sexual reproduction;
– it facilitates both enzyme extraction and purification,
improving the overall management of the productive
process;
– it is economically more convenient compared to the
CHO-technology, thus setting the conditions for a
more affordable therapy of Gaucher disease.
Rice-derived rhGCase displays all the molecular char-
acteristics and pharmaceutical prerequisites for ERT of
Gaucher disease, being highly equivalent to the native
human enzyme.
Methods
Construction of the plant expression vector pTRS0_GCase
This vector was developed from the commercial plasmid
pCAMBIA1300 [GenBank: AF234296] by introductionof the GCase cassette into the Eco RI site. The GCase
cassette was designed to harbour the rice storage protein
glutelin 4 promoter (GluB4pro), the human GCase CDS
and the nopaline synthase terminator of Agrobacterium
tumefaciens (NOS-ter).
The GluB4pro sequence was PCR-isolated from rice
genomic DNA (Oryza sativa ssp. japonica, var. CR W3)
with primers designed on the basis of GenBank acc. No.
AY427571 (forward 5’- GCATGCGAATTCTACAGGG
TTCCTTGCGTG-3’; reverse 5’-TCTAGAAGCTATTT
GAGGATGTTATTGGAA-3’). In order to improve
rhGCase expression levels, the native 5’-UTR was substi-
tuted with the LLTCK leader (De Amicis et al. 2007).
RhGCase targeting to the protein storage vacuoles
(PSVs) was attempted with the transit peptide of rice
glutelin 4 (Uniprot code P14614 [1–24]). Promoter,
LLTCK leader and transit peptide sequences were ligated
immediately upstream the GCase mature polypeptide
CDS [GenBank: M16328, nt 553–2043]; the GCase cod-
ing sequence was obtained by RT-PCR from human pla-
cental total RNA. The expression cassette was
completed by the addition of nos-ter.
After cloning into the final expression vector
pTRS0_GCase (Figure 12), all sequences were verified
on both strands.
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primary transformants
The engineered vector was introduced into Agrobacter-
ium tumefaciens, strain EHA105, by electroporation.
Rice transformation was carried out according to Hiei
et al. (1994) with minor modifications. Putatively trans-
formed (i.e. hygromycin resistant) plants were potted in
peat, hardened in a greenhouse and maintained until
seed maturation. For PCR analyses, genomic DNA was
extracted from young leaves according to Doyle and
Doyle (1990) and analysed with two primer pairs (for-
ward1 5’-TCTAGAATGGCCACCATTGC-3’ and re-
verse1 5’-GAGCTCTCACTGGCGATGCC-3’; forward2
5’-AATAGCTGCGCCGATGGTTT-3’ and reverse2 5’-
ACCACGGCCTCCAGAAGAAG-3’) with the following
PCR conditions: one cycle of 5 min at 95°C, 40 cycles of
40 s at 95°C, 40 s at 58°C and 2 min at 72°C, followed by
a final extension step of 5 min at 72°C.
In order to estimate GCase copy number in transgenic
rice plants, we used the method of real-time quantitative
PCR developed by Ding et al. (2004) in which the rice
sucrose phosphate synthase (SPS) gene represents the
endogenous reference standard. The oligonucleotide pri-
mers and TaqMan probes (Table 2) were designed with
the Primer 3 Output software (http://frodo.wi.mit.edu).
All probes had the Blackhole Quencher 1 at the 3’ end,
whereas in 5’ they were labelled with the fluorescent re-
porter dye Texas Red (SPS-P) or Joe (GCase-P).
RT-PCR was performed with the thermal cycler iCy-
cler iQ real-time PCR detection system (Bio-Rad) and
1xPlatinum Quantitative PCR SuperMix UDG (Invitro-
gen). The amplification conditions consisted of one cycle
of 3 min at 50°C and 3 min at 95°C, followed by 50 cycles
of 15 s at 95°C and 1 min at 60°C. In order to generate
standard curves for DNA quantification, SPS- and
GCase-harbouring plasmids were serially diluted and
analyzed.
Protein extraction
Protein extracts for Western blot analyses were prepared
as follows: five dehulled seeds were ground with 1 mL of
extraction buffer (500 mM NaCl in 50 mM Tris-HCl








GCase-P GAGAGTACACGCAGTGGGCGACGhomogenate was incubated at RT for 5 min under agi-
tation and then centrifuged at 15000 × g for 45 min
at 4°C. The supernatant (30 μg soluble protein) was
directly used for SDS-PAGE.
Protein extracts for ELISA analyses were obtained
homogenizing five dehulled seeds with 10 mL extraction
buffer, as above.
To determine rhGCase expression levels, 40 dehulled
seeds were milled and thoroughly homogenized in
80 mL extraction buffer and stirred on ice for 1 h. The
extract was centrifuged at 20000 × g, 4°C, for 40 min.
The supernatant was collected and stored for DAS-
ELISA.
Gel electrophoresis and staining
SDS-PAGE was performed under standard conditions,
using the Mini Protean II apparatus (BioRad), loading
the samples in 10% polyacrylamide gels after denatur-
ation for 5 min. Commercial molecular weight markers
(Fermentas) and commercial imiglucerase were used to
assess the molecular weight of rhGCase. Gels were
stained with EZBlueTM Gel Staining Reagent (Sigma
Aldrich) or with ProteoSilverTM Silver Stain kit (Sigma
Aldrich).
Western blot
The extracts prepared as above were denaturated under
non-reductive conditions and loaded in a 10% polyacryl-
amide gel together with Precision Protein Standard
(BioRad). The gel was electroblotted to a 0.2 μm PVDF
membrane (Millipore) with the Trans-blot SD apparatus
(BioRad). The blot was blocked with 7.5% non-fat dry
milk (Oxoid) in PBS for 1 h at RT. After 3 washes with
PBS Tween 0.1%, the primary rabbit polyclonal antibody,
produced using commercial imiglucerase (Genzyme
Corp., Sanofi Aventis) as antigen, was diluted 1:1000 in
the blocking buffer and the blot was incubated for 1 h at
RT. Then, the HRP-conjugated secondary antibody
(Sigma Aldrich) was diluted 1:10000 and the blot in-
cubated again for 1 h at RT. After final washes, chemi-
luminescence was developed with ECL plus (GE
Healthcare). To identify the best transgenic lines, sam-
ples showing a strong signal were further evaluated by
Western blotting using two- or four-fold diluted
supernatants.
RhGCase quantification by DAS-ELISA
A double antibody sandwich ELISA was used to quantify
rhGCase in both crude protein extracts and chromato-
graphic fractions. Capture antibody was obtained from
the same rabbit antiserum used in Western analyses,
purified by affinity chromatography on imiglucerase
derivatized resin. Detecting antibody was produced by
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were purchased from Davids Biotechnologie (Germany).
SPL maxi binding plates (SPL, Korea) were coated
with 2 ng/μL of capture antibody in coating solution
(30 mM NaCl, 2.5 mM sodium phosphate buffer,
15 mM sodium azide, pH 7.4), 100 μL per well. Coating
was performed by stirring the plate at 37°C for 20 min.
Then, the plate was blocked with 3% BSA solution in
PBS with 15 mM sodium azide, at 37°C for 20 min,
300 μL per well. Crude extracts were diluted 1:30 in di-
lution buffer (1% BSA, PBS-Tween 20 0.1% solution,
pH 7.4), added to the plate and incubated at 37°C for
20 min, 100 μL per well. Chromatographic fractions
were differently diluted case by case. After three washes
with PBS-Tween 20 0.1%, detecting antibody was applied
at 0.8 ng/μL in dilution buffer, 50 μL per well at 37°C for
20 min. After four washes, detection was performed
using TMB Liquid substrate system (Sigma Aldrich),
100 μL per well; the reaction was stopped with 1 M
HCl, 100 μL per well. Plates were read with Modulus
II microplate reader (Turner Biosystem) at 450 nm.
For rhGCase quantification, a standard curve was built
with the following commercial imiglucerase concen-
trations: 250, 125, 62.5, 31.3 15.6, 7.8, 3.9, 2.0 pg/μL
in dilution buffer, 100 μL per well.
To evaluate rhGCase expression levels in polished
seed, serial extracts were diluited 1:100 in ELISA dilu-
tion buffer and analyzed separately. The total rhGCase
amount was calculated and expressed as mg per kg of
flour.
Tissue-specific expression analyses
In order to demonstrate the endosperm-specific expres-
sion of rhGCase, Western blot analyses were performed
on crude protein extracts obtained from different
organs/tissues at the vegetative and reproductive stage.
Protein samples were taken from: leaf blade, leaf sheath,
stem internode, stem node, root, rachis, glume and husk,
unfertilized ovule, immature anther, mature pollen, im-
mature embryo, endosperm, using Tris-HCl 50 mM,
0.5 M NaCl, pH 7.0 in mortar and pestle. To extract
proteins, the resulting homogenates were incubated on
ice for 1 h under agitation and then centrifuged at
15000 × g for 45 min at 4°C. Protein concentration of
the supernatants was determined by a standard Bradford
assay (Bradford 1976). Samples (7–15 μg) were loaded in
Laemmli buffer (Laemmli 1970) into a 10% polyacryl-
amide gel together with a molecular weight marker
(Sigma Aldrich) and a positive control (commercial imi-
glucerase). At the end of the run, proteins were stained
overnight with Coomassie and destained with 20%
methanol and 10% acetic acid. A second electrophoretic
gel was used to blot the proteins onto a PVDF mem-
brane and perform a Western blot analysis as reportedin the previous paragraph. SDS-PAGE and Western blot-
ting were performed also on samples extracted from
wild type CR W3. Results achieved by Western blotting
were eventually confirmed in DAS-ELISA.
Electron and immunoelectron microscopy
Unlabeled osmium-treated samples were prepared
according to Musetti et al. (2011). For immunoelectron
microscopy, immature rice seeds (approx. 10–15 days
after flowering) were fixed in 0.2% glutaraldehyde, rinsed
in 0.1 M phosphate buffer, pH 7.4, dehydrated in ethanol
(25, 50, 75%, 30 min each step, then 100% for 1 h), then
infiltrated in LR White Resin (LRW, London Resin) with
the following ratio: LRW:ethanol 1:2 for 30 min, LRW:
ethanol 2:1 for 30 min, and 100% LRW (two changes:
after 1 h, then overnight) at RT. The samples were em-
bedded in fresh LRW resin in BEEM capsules and poly-
merized at 60°C for 24 h.
Ultra-thin sections (60–70 nm) were cut with the
ultramicrotome LKB Nova (Reichter) and mounted on
nickel grids (Electron Microscopy Sciences) for immu-
nolocalization. Sections were incubated with Normal
Goat Antiserum (Aurion) diluted 1:30 in buffer C
(0.05 M Tris-HCl, pH 7.6, 0.2% BSA) for 15 min and
then with the anti-GCase serum diluted 1:500 in buffer
C for 1 h at RT. After washes, the sections were incu-
bated for 1 h with a solution of goat anti-rabbit antibody
conjugated with 15 nm colloidal gold (Aurion) diluted
1:40 in 0.02 M Tris-HCl, pH 8.2, containing 0.9% NaCl
and 1% BSA. Sections were stained with 0.1% lead citrate
(Reynolds 1963) and examined with the CM10 transmis-
sion electron microscope (Philips).
Seed viability
One hundred non-vernalized seeds produced by the best
transgenic lines were placed onto moistened paper and
incubated in petri dishes at 28/22°C d/n, 16/8 h d/n;
seeds were daily controlled to determine their viability
using untransformed, non-vernalized CR W3 seed as
control.
RhGCase purification
Transgenic rice seed was dehulled, polished with the
TO-92 equipment (Satake) and milled in a coffee
blender. Rice flour was suspended in cold methanol
(1:5 w/v), stirred on ice for 5 min and centrifuged for
15 min at 14000 × g. After the supernatant was dis-
carded, the pellet was extracted with 2 mM sodium cit-
rate, pH 5.5 (1:5 w/v) and centrifuged for 15 min at
14000 × g; this step was done to eliminate the low-salt
soluble protein fraction and for a better efficiency it was
repeated twice. At the end of pretreatment, the pellet
was extracted with 0.5 M NaCl in 50 mM Tris-HCl buf-
fer, pH 7.0 (1:5 w/v). The extract was stirred for 5 min
Patti et al. Rice 2012, 5:34 Page 13 of 15
http://www.thericejournal.com/content/5/1/34at RT and then centrifuged for 15 min at 14000 × g to re-
cover the supernatant. In order to extract all the
rhGCase protein stored in rice seed, the extraction pro-
cedure was repeated three times and the supernatants
were pooled and further clarified by centrifugation at
14000 × g for 45 min at 4°C.
RhGCase was purified using a three-step purification
process involving HIC (Hydrophobic Interaction Chro-
matography) for capture, IEC (Ion Exchange Chroma-
tography) for intermediate purification and GF (Gel
Filtration) for the polishing step. All chromatographies
were performed with the AKTA Prime purification sys-
tem (GE Healthcare).
For HIC, two 5-mL HiTrap Octyl FF columns (GE
Healthcare) were serially connected and equilibrated with
one column volume of loading buffer (10 mL of 200 mM
ammonium sulphate in 50 mM Tris-HCl buffer, pH 7.0).
A 3 M ammonium sulphate solution was added to the
clarified extract to reach a final concentration of 200 mM
ammonium sulphate. After filtration with 0.2 μm filter
(Millipore), 300 mL of the extract were applied to the col-
umn at a 5 mL/min flow-rate. The flow-through was
reloaded onto the column until three loading volumes
were passed. The flow-through was then collected and
stored until analysis. The column was washed with 14 col-
umn volumes (140 mL) of 15 mM sodium citrate buffer,
pH 5.5. Elution was carried out by increasing ethylene gly-
col concentrations from 0% to 50% in 15 mM sodium cit-
rate buffer, pH 5.5. One-mL fractions were collected and
tested in ELISA. Positive fractions (from number 3 to
number 15) were pooled and loaded in a 1-mL HiTrap SP
HR column (GE Healthcare); rhGCase was eluted in 5-mL
fractions by a continuous gradient from 60 mM to
200 mM of NaCl in 20 column volumes (20 mL).
Gel filtration was used as the final polishing step. A
HiPrep 16/60 Sephacryl S-100 High Resolution column
(GE Healthcare) was equilibrated with 15 mM sodium
citrate and 150 mM NaCl, pH 5.5; the column was then
loaded with the DAS-ELISA positive IEC fraction (num-
ber 3), reduced to 500 μL by Amicon Ultra-15 (MWCO
30 kDa, Millipore) and run at a flow-rate of 0.5 mL/min.
In order to recognize the rhGCase-containing peak,
a preliminary GF was performed with commercial
imiglucerase.
Enzymatic assay
RhGCase activity was assayed using 4-MUG (4-
methylumbelliferyl β-D-glucoside, Sigma Aldrich) as
substrate. The reaction buffer contained 100 mM so-
dium acetate buffer, pH 5.5, 0.5% w/v taurocholate and
10 mM 4-MUG, 50 μL per well. The reaction was car-
ried out at 37°C for 30 min and finally stopped with
200 μL 100 mM glycine-NaOH, pH 10.0. Fluorescence
was read at 410–460 nm with the fluorimeter ModulusII microplate reader (UV Optical kit, Turner Biosystem)
following excitation at 365 nm. A standard curve was
built with 2.5-5.0 nmol 4-MU (4-methylumbelliferone,
Sigma Aldrich) in reaction buffer, 200 μL per well.
Peptide mass fingerprinting and N-terminal sequencing
Peptide mass fingerprinting was performed by MALDI-
TOF technology (Perkin Elmer). A purified rhGCase
sample was electrophoresed and stained with Coomassie
Blue R-250 staining; the band of interest was cut,
washed at 37°C with a 100 mM NH4HCO3 and aceto-
nitrile (ACN) (50:50 v/v) solution, ground and dehy-
drated with ACN. The protein was reduced with 10 mM
dithiothreitol, alkylated with 50 mM iodoacetamide
(IAA) and overnight digested with 50 ng/μL trypsin
(Promega) at 37°C. After a further treatment with 2%
formic acid and 60% ACN, peptides were purified with a
zip-tip C18 (Millipore), removing the contaminants with
0.1% TFA washes. Peptides were slowly eluted with
ACN and 0.1% TFA (70:50), mixed with a CHCA (α-
cyano-4-hydroxycinnamic acid) matrix and spotted onto
a MALDI plate for analysis.
For N-terminal sequencing, a purified rhGCase sample
was electrophoresed and blotted onto a PVDF mem-
brane. The rhGCase band was identified by Coomassie-
Blue staining. The N-terminal sequence was determined
by Primm Srl (Milan, Italy) using the Edman degradation
method (Edman 1950).
Glycan structure analyses
Glycosylation patterns were determined using exoglyco-
sidase digestion and MALDI-TOF analyses. In particular,
a purified rhGCase sample was run on SDS-PAGE and
the band of interest, identified by Coomassie-Blue stain-
ing, was cut out and incubated with PNGase F, i.e. pep-
tide-N(4)-(N-acetyl-β-glucosaminyl) asparagine amidase
F, to remove the oligosaccharide chains connected to the
amidic group of asparagine residues. Oligosaccharide
chains were then analysed by MALDI-TOF according to
Siemiatkoski et al. (2006).
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